首页> 外文会议>Cell culture engineering conference >OVERCOMING SCALE-UP CHALLENGES FOR A FIRST-IN-HUMAN (FIH) ANTIBODY PRODUCTION PROCESS AT THE 2000L SCALE: SUCCESSFUL OPTIMIZATION OF BIOREACTOR EQUIPMENT AND HARVEST CONDITIONS TO IMPROVE PROCESS PERFORMANCE AND PRODUCT YIELD
【24h】

OVERCOMING SCALE-UP CHALLENGES FOR A FIRST-IN-HUMAN (FIH) ANTIBODY PRODUCTION PROCESS AT THE 2000L SCALE: SUCCESSFUL OPTIMIZATION OF BIOREACTOR EQUIPMENT AND HARVEST CONDITIONS TO IMPROVE PROCESS PERFORMANCE AND PRODUCT YIELD

机译:克服2000L规模人类首次(FIH)抗体生产过程的规模挑战:生物反应器设备的成功优化和提高过程性能和产品产量的收割条件

获取原文

摘要

During the development and scale-up of a FIH fed-batch cell culture process, we have encountered two major challenges that impacted culture performance and harvest process yield significantly. The first challenge relates to the oxygen requirement for this particular process, where a higher oxygen demand was observed compared to our platform processes. The high oxygen demand is met by increasing agitation and sparging of air and oxygen in bioreactors, but also negatively impacted cell health due to higher gas entrance velocities (GEV) from the higher sparging rate. The observation is exemplified in the manufacturing scale which significantly impacted cell culture performance and antibody production. Further exacerbating this issue, many sparger holes were later found to be plugged leading to a theoretical GEV as high as 300 m/s. Extensive troubleshooting studies were carried out at small scale to confirm the impact of high GEV on this antibody production process and led to the re-design of the sparger for the manufacturing scale. Once implemented, the new sparger successfully mitigated the issue. The second challenge was relating to harvest operation, where the final membrane filter was clogged at the manufacturing scale. Studies were performed at the pilot scale to evaluate different solutions including increasing depth filter area, testing different types of the final filter, and changing the chase buffer at the manufacturing scale. In the end, successful implementation of the new sparger design and optimized harvest conditions led to comparable process performance between the manufacturing scale and the pilot scale. The final process resulted not only in an increase in the overall product yield, but also prevented the need of filter change-outs during the harvest operation, therefore, significantly improving manufacturing ease.
机译:在FIH分批补料细胞培养过程的开发和规模扩大过程中,我们遇到了两个主要挑战,这些挑战极大地影响了培养性能和收获过程的产量。第一个挑战与该特定工艺的氧气需求有关,与我们的平台工艺相比,该氧气需求更高。氧气的高需求可以通过增加生物反应器中空气和氧气的搅动和喷射来解决,但是由于更高的喷射速率会导致更高的气体进入速度(GEV),因此也会对细胞健康产生负面影响。该观察以生产规模为例,该生产规模显着影响细胞培养性能和抗体生产。进一步加剧了这一问题,后来发现许多喷孔被堵塞,导致理论GEV高达300 m / s。在小规模下进行了广泛的故障排除研究,以确认高GEV对这种抗体生产过程的影响,并导致重新设计了喷枪,以实现生产规模。实施后,新的喷头成功解决了该问题。第二个挑战与收获操作有关,最终的膜过滤器在生产规模上被堵塞。在中试规模上进行了研究,以评估不同的解决方案,包括增加深度过滤器面积,测试最终过滤器的不同类型以及在制造规模上更改追赶缓冲区。最后,成功实施新的喷头设计和优化的收获条件导致了制造规模和中试规模之间可比的工艺性能。最终的过程不仅提高了整体产品的产量,而且避免了在收割过程中更换过滤器的需要,因此,极大地提高了制造的便利性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号